NCT06763328: Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy |
|
|
| Recruiting | 3 | 200 | US | Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Educational Intervention, Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational, Extended Release Metformin Hydrochloride, ER Metformin Hydrochloride, Extended-release Metformin Hydrochloride, Glucophage XR, Glumetza, Metformin Hydrochloride Extended Release, Questionnaire Administration | City of Hope Medical Center, National Cancer Institute (NCI) | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Invasive Breast Carcinoma | 06/29 | 06/29 | | |
